These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 33021318)

  • 1. Potential clinical use of azithromycin against gastroenteritis-causing pathogens other than Campylobacter.
    Casanovas-Moreno-Torres I; Gutiérrez-Soto B; Modovan TD; Expósito-Ruiz M; Navarro-Marí JM; Gutiérrez-Fernández J
    New Microbiol; 2020 Oct; 43(4):198-200. PubMed ID: 33021318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (2003).
    Streit JM; Jones RN; Toleman MA; Stratchounski LS; Fritsche TR
    Int J Antimicrob Agents; 2006 May; 27(5):367-75. PubMed ID: 16647842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Susceptibility to azithromycin and other antibiotics in recent isolates of Salmonella, Shigella and Yersinia].
    Martín-Pozo A; Arana DM; Fuentes M; Alós JI
    Enferm Infecc Microbiol Clin; 2014; 32(6):369-71. PubMed ID: 24698008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility antibiotic screening reveals high rates of multidrug resistance of Salmonella, Shigella and Campylobacter in HIV infected and uninfected patients from Mozambique.
    Hlashwayo DF; Noormahomed EV; Bahule L; Benson CA; Schooley RT; Sigaúque B; Barrett KE; Bila CG
    BMC Infect Dis; 2023 Apr; 23(1):255. PubMed ID: 37085752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of azithromycin against bacterial enteric pathogens.
    Gordillo ME; Singh KV; Murray BE
    Antimicrob Agents Chemother; 1993 May; 37(5):1203-5. PubMed ID: 8390813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of azithromycin against clinical isolates of family enterobacteriaceae: A comparison of its minimum inhibitory concentration by three different methods.
    Chayani N; Tiwari S; Sarangi G; Mallick B; Mohapatra A; Paty BP; Das P
    Indian J Med Microbiol; 2009; 27(2):107-10. PubMed ID: 19384031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens.
    Carlson JR; Thornton SA; DuPont HL; West AH; Mathewson JJ
    Antimicrob Agents Chemother; 1983 Oct; 24(4):509-13. PubMed ID: 6651278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.
    Goodman LJ; Fliegelman RM; Trenholme GM; Kaplan RL
    Antimicrob Agents Chemother; 1984 Apr; 25(4):504-6. PubMed ID: 6732220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the sensitivity of enteropathogenic bacteria to nifurzide].
    Gavinet AM; Mégraud F
    Pathol Biol (Paris); 1987 May; 35(5):542-4. PubMed ID: 3302859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale of azithromycin prescribing practices for enteric fever in India.
    Rai S; Jain S; Prasad KN; Ghoshal U; Dhole TN
    Indian J Med Microbiol; 2012; 30(1):30-3. PubMed ID: 22361757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial-resistant Shigella sonnei: limited antimicrobial treatment options for children and challenges of interpreting in vitro azithromycin susceptibility.
    Jain SK; Gupta A; Glanz B; Dick J; Siberry GK
    Pediatr Infect Dis J; 2005 Jun; 24(6):494-7. PubMed ID: 15933557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of rifaximin against clinical isolates of Escherichia coli and other enteropathogenic bacteria isolated from travellers returning to the UK.
    Hopkins KL; Mushtaq S; Richardson JF; Doumith M; de Pinna E; Cheasty T; Wain J; Livermore DM; Woodford N
    Int J Antimicrob Agents; 2014 May; 43(5):431-7. PubMed ID: 24661532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015.
    Jakubů V; Zavadilová J; Fabiánová K; Urbášková P
    Cent Eur J Public Health; 2017 Dec; 25(4):282-286. PubMed ID: 29346850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of azithromycin (CP-62,993), a novel macrolide, against enteric pathogens.
    Jones K; Felmingham D; Ridgway G
    Drugs Exp Clin Res; 1988; 14(10):613-5. PubMed ID: 2854515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of bacteria isolated from acute gastrointestinal infections to rifaximin and other antimicrobial agents in Mexico.
    Novoa-Farías O; Frati-Munari AC; Peredo MA; Flores-Juárez S; Novoa-García O; Galicia-Tapia J; Romero-Carpio CE
    Rev Gastroenterol Mex; 2016; 81(1):3-10. PubMed ID: 26525276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased Susceptibility to Azithromycin Among Clinical Shigella Isolates from China.
    Zhang C; Zhang R; Yu Q; Chu X; Sun J; Liu Q
    Microb Drug Resist; 2017 Jul; 23(5):596-601. PubMed ID: 27841958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility testing of bacteria that cause gastroenteritis.
    Humphries RM; Schuetz AN
    Clin Lab Med; 2015 Jun; 35(2):313-31. PubMed ID: 26004645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in antibiotic susceptibility of enteric fever isolates in East London.
    Dave J; Sefton A; de Pinna E; Woodford N; Meade R; Jordan M; Grant K; Holliman R; Millar M
    Travel Med Infect Dis; 2015; 13(3):230-4. PubMed ID: 25964222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years.
    Hoge CW; Gambel JM; Srijan A; Pitarangsi C; Echeverria P
    Clin Infect Dis; 1998 Feb; 26(2):341-5. PubMed ID: 9502453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.